Autres langues ApicHope Pharmaceutical Group Co., Ltd.

Actions

300723

CNE1000035J7

Produits pharmaceutiques

Cours en clôture Shenzhen S.E. 08/10/2026			Varia. 5j.	Varia. 1 janv.
32,84 ^CNY	-1,29%		-1,29%	-2,12%

04/09	ApicHope Pharmaceutical obtient l'approbation pour une solution orale de sertraline en Chine	MT
04/09	Le traitement contre la goutte d'ApicHope Pharmaceutical atteint son critère d'évaluation principal lors d'un essai clinique	MT

Autres langues

04/09	ApicHope Pharmaceutical Obtains Approval for Sertraline Oral Solution in China
04/09	ApicHope Pharmaceutical's Gout Drug Meets Primary Endpoint in Drug Trial
26/08	ApicHope Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026
18/08	ApicHope Pharmaceutical Gets China Clinical Trial Approval for Weight Control Pill
27/07	ApicHope Pharmaceutical Signs Clinical Trial Contract with Boji Medical Technology for Obesity Drug; Shares Rise 4%
24/07	Declaration of Voting Results by ApicHope Pharmaceutical
24/07	ApicHope Pharmaceutical Receives China NMPA Drug Registration Certificate for Anti-Gout Tablets
13/07	ApicHope Pharmaceutical Receives Shareholder Proposal from Hanxiong Li
11/06	China Approves ApicHope Subsidiary's Clinical Trials for Leukemia Drug
22/05	ApicHope Pharmaceutical Unit Gets China Nod for Hemostatic Drug
23/04	ApicHope Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
23/04	ApicHope Pharmaceutical Q1 net profit up 950.4% y/y
23/04	ApicHope Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
14/03	ApicHope Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on December 15, 2025, has expired.
12/02	ApicHope Pharmaceutical Says 15 Drugs Selected in China's Bulk Procurement Tender
05/01	Tranche Update on ApicHope Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on December 15, 2025.
30/12	Degron Therapeutics Inc. announced that it has received funding from ApicHope Pharmaceutical Group Co., Ltd.
15/12	ApicHope Pharmaceutical Group Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.
15/12	ApicHope Pharmaceutical Gets Nod for Qinxiang Qingjie Oral Liquid to Be Protected Traditional Chinese Medicine Variety
15/12	ApicHope Pharmaceutical Group Co., Ltd. authorizes a Buyback Plan.
12/12	ApicHope Pharmaceutical's Guangzhou Subsidiary Gets Drug Certificate for Antibiotic
25/11	ApicHope Pharmaceutical's Unit Gets Registration Certificate for Alzheimer's Treatment Drug: Shares Up 9%
29/10/25	ApicHope Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
20/10/25	ApicHope Pharmaceutical Unit Gets China Approval for Muscle Weakness Treatment
29/09/25	ApicHope Pharmaceutical Gets China Approval for L-Carnitine Solution